RxDoctor Payments Data

Hector Hernandez Hern, MD

Internal Medicine · San Juan, PRNPI 1962576793

Payments from drug & device makers

$1,485in general payments, 2019–2025

Across 54 payments — averaging $27.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$427
  • Johnson & Johnson$371
  • Sanofi-aventis U.S. LLC$203
  • Boehringer Ingelheim$135
  • Biogen$108
  • Pfizer$99
  • plus $143 from 4 others

What the payments were for

  • Food & beverage$1,41495%
  • Education$725%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca21$427
Johnson & Johnson10$371
Sanofi-aventis U.S. LLC10$203
Boehringer Ingelheim6$135
Biogen1$108
Pfizer2$99
E.r. Squibb & Sons, L.L.C.1$75
AbbVie1$35
Pfizer Pharmaceuticals LLC1$20
Merck1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,485 in reported general payments places this provider in the 70th percentile of 1,043 internal medicine providers in Puerto Rico.

See all internal medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$3,366
Medicare patients
13
Services billed
38

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol172$111,022
EliquisApixaban166$104,880
JanumetSitagliptin Phos/Metformin Hcl94$53,750
JardianceEmpagliflozin52$39,251
XareltoRivaroxaban46$29,605
SynthroidLevothyroxine Sodium478$28,611
TradjentaLinagliptin36$22,982
Janumet XrSitagliptin Phos/Metformin Hcl37$20,500
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$14,834
LantusInsulin Glargine,hum.Rec.Anlog102$12,028
Candesartan Cilexetil205$11,711
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate53$11,585
Stiolto RespimatTiotropium Br/Olodaterol Hcl22$10,801
Xigduo XrDapaglifloz Propaned/Metformin21$10,693
LokelmaSodium Zirconium Cyclosilicate12$10,137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Lokelma$427$121,159184 claims
PfizerEliquis$99$104,880166 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Spiriva Respimat$135$82,176125 claims
MerckJanumet, Janumet Xr, Januvia$13$81,797144 claims
AbbVieSynthroid, Lumigan$35$33,251496 claims
Johnson & JohnsonXarelto$371$29,60546 claims
Sanofi-aventis U.S. LLCLantus$203$12,028102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,043 internal medicine providers in Puerto Rico.

Other internal medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →